DALLAS, July 26, 2005 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated profile coverage for Gulf Biomedical Corporation (Pink Sheets:GBIC). Mr. Pentony spoke about Gulf Biomedical: "This is a company centered on a very interesting new product. It is clear that this is a must-see product. GBIC envisions a very large potential market, and has put together a plan to reach that market."
As reported recently, Gulf Biomedical reports they have contracted with R.O.V.E. Medical Clinic to conduct a scientific, double-blind, clinical study of the effectiveness of HairMagic(tm), the new two-step hair restoration breakthrough that has worked -- to actually grow new hair -- on 100% of 70 test cases to date. The clinic will arrange 60-day trials of the all-natural, no-side-effects product utilizing volunteer participants in Houston and Orange, Texas.
Meanwhile, Gulf Biomedical will follow up its initial test e-mail sales campaign with a follow-on campaign to 30-million over-50, opt-in recipients. The online sales campaign comes after HairMagic scored a 100% success rate in its treatment of 70 hair loss patients. After only four weeks, each of the 70 reported the sight of quarter-inch tendrils of new hair growing on their heads where none grew before.
To view our StockGuru.com profile of Gulf Biomedical, please visit:
http://stockguru.com/profiles/gbic/index.aspx
About StockGuru.com
StockGuru.com and TalkingStocks.com are two key destinations on the Internet for those seeking information on smallcap and microcap companies. The web sites feature companies in profile campaigns, key executive interviews, email alerts, and special reports authored by our financial writers. The web sites set the standard for communication with investors. To feature a company or to get more information, please contact our publisher at (469) 252-3031 and publisher@stockguru.com.
This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of l995 relating to aspects of the Company's operations and strategies. Important factors could occur to cause actual results to differ materially from those described herein. There is a risk that the Company may incur losses. Readers are urged to consider these cautionary statements carefully. Forward-looking statements speak only as of the date of this news release, and the Company disclaims any obligations to update such statements.
Disclosure: Pentony Enterprises LLC and TalkingStocks.com LLC have been compensated $10,000 by the company for profile coverage. Neither TalkingStocks.com, LLC, nor Pentony Enterprises, LLC, are registered investment advisers or broker/dealers. TalkingStocks.com, LLC and Pentony Enterprises, LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.